Mike Poole, director, Global Health Office of the President, is responsible for coordinating and evaluating new investment opportunities in R&D technologies, and oversees Global Health leadership engagements and strategic operations.
Prior to joining the foundation in 2014, Mike served as vice president and head of Neuroscience Innovative Medicines at AstraZeneca, where he managed drug discovery and development projects in collaboration with a network of academic and industry partners. Prior to joining AstraZeneca, Mike was chief medical officer for Link Medicine, and previously served as chief medical officer for Hypnion. He has also held a number of international leadership roles at Pfizer and Wyeth.
Mike earned his medical degree at the University of California, San Diego. He trained in internal medicine at Strong Memorial Hospital, University of Rochester and in neurology at the University of Michigan Medical School.